A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho University, in collaboration with the Duke University Medical Center in the ...
The US Food and Drug Administration (USFDA) has said Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues. In its latest Enforcement Report ...
Indian pharmaceutical giants Sun Pharma and Zydus Pharmaceuticals are recalling certain products from the US market due to manufacturing concerns, according to the latest Enforcement Report from the ...
The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist ...
New Delhi: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based Sun ...
Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based Sun ...
Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The recalls affect Morphine Sulfate and Nelarabine Injection. New Delhi, Mar 16 ...
The New Jersey-based Sun Pharmaceutical Industries, Inc is recalling 9,840 bottles of Morphine Sulfate extended-release tablets for 'Failed Dissolution Specifications', the US health regulator ...
Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex ...
Zydus Lifesciences has entered exclusive negotiations ... following which the Ahmedabad-based pharma company will make a mandatory cash offer for the remaining shares, valuing the potential ...
Global MedTech Market attracts Zydus Interest; Company acquires French Device Maker for $326 million
New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...
The exports of the Indian pharmaceutical sector have witnessed a solid performance ... producing generic versions of high-demand drugs such as Revlimid and Mirabegron. Zydus Life has reported an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results